SYPRINE (nda019194)- (250MG)

Generic Name	TRIENTINE HYDROCHLORIDE	Innovator	BAUSCH
Dosage	250MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Syprine is indicated in the treatment of patients with Wilson’s disease who are intolerant of penicillamine.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
11	0	8

Other Developers

Total Other Developers	10

Drugs with Suitability

Drugs with Suitability	Yes

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
250MG	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	7

Manufacturing Details of SYPRINE